AMADIX

About

AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people’s lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear.

Participate in the DxPx Pitch competition virtual juror and join DxPx Conference for 499 EUR.